Phylogeny of the genus Flavivirus, J. Virol, vol.72, pp.73-83, 1998. ,
Zika virus. I. Isolations and serological specificity, Trans. R. Soc. Trop. Med. Hyg, vol.46, pp.509-520, 1952. ,
Zika virus outbreak on Yap Island, Federated States of Micronesia, N. Engl. J. Med, vol.360, pp.2536-2543, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00734543
Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, Emerg. Infect. Dis, vol.14, pp.1232-1239, 2007. ,
Zika virus, French polynesia, South pacific, Emerg. Infect. Dis, vol.20, pp.1085-1086, 2013. ,
Zika virus outbreak, Brazil. Emerg. Infect. Dis, vol.21, pp.1885-1886, 2015. ,
Co-infection with Zika and dengue viruses in 2 patients, Emerg. Infect. Dis, vol.21, pp.381-382, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01114780
First report of autochthonous transmission of Zika virus in Brazil, Mem. Inst. Oswaldo Cruz, vol.110, pp.569-572, 2015. ,
Zika virus disease in Colombia-Preliminary report, N. Engl. J. Med, 2016. ,
Zika virus infection complicated by Guillain-Barre syndrome-Case report, 2013. ,
Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study, Lancet, vol.387, pp.1531-1539, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01453407
Association between Zika virus and microcephaly in French Polynesia, A retrospective study, vol.387, pp.2125-2132, 2016. ,
Microcephaly in north-east Brazil: A retrospective study on neonates born between, Bull. World Health Organ, vol.94, pp.835-840, 2012. ,
Zika virus genome from the Americas, Lancet, vol.387, pp.227-228, 2016. ,
, Clin. Microbiol. Rev, vol.29, pp.487-524, 2016.
Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes, Nature, vol.545, pp.482-486, 2017. ,
Zika virus evolution and spread in the Americas, Nature, vol.546, pp.411-415, 2017. ,
A single mutation in the prM protein of Zika virus contributes to fetal microcephaly, vol.358, pp.933-936, 2017. ,
Knowledge gaps, unmet needs, and research priorities, Lancet Infect. Dis, vol.17, pp.88-100, 2017. ,
Structural basis of potent Zika-dengue virus antibody cross-neutralization, Nature, vol.536, pp.48-53, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01408100
The 3.8 A resolution cryo-EM structure of Zika virus, Science, vol.352, pp.467-470, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01439629
Contribution of intertwined loop to membrane association revealed by Zika virus full-length NS1 structure, EMBO J, vol.35, pp.2170-2178, 2016. ,
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus, Proc. Natl. Acad. Sci, vol.113, pp.7852-7857, 2016. ,
cross-reactivity, and function of antibodies elicited by Zika virus infection, Science, vol.353, pp.823-826, 2016. ,
Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure, Virus Res, 2017. ,
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity, vol.356, pp.175-180, 2017. ,
Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors ,
Dengue antibody-dependent enhancement: Knowns and unknowns. Microbiol. Spectr. 2014, 2 ,
Humoral cross-reactivity between Zika and dengue viruses: Implications for protection and pathology, Emerg. Microbes Infect, vol.6, 2017. ,
Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species, PLoS Curr, vol.8, 2016. ,
Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance, Am. J. Trop. Med. Hyg, vol.81, pp.825-833, 2009. ,
Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based technique, Methods Mol. Biol, vol.1138, pp.27-39, 2014. ,
Easy and inexpensive molecular detection of dengue, chikungunya and zika viruses in febrile patients, Acta Trop, vol.163, pp.32-37, 2016. ,
Zika virus seroprevalence, Emerg. Inf. Dis, vol.23, pp.669-672, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01521256
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions, Proc. Natl. Acad. Sci, vol.109, pp.7439-7444, 2012. ,
Neutralization and antibody-dependent enhancement of dengue viruses, Adv. Virus Res, vol.60, pp.421-467, 2003. ,
Dissecting the human serum antibody response to secondary dengue virus infections ,
Reduced risk of disease during postsecondary dengue virus infections, J. Infect. Dis, vol.208, pp.1026-1033, 2013. ,
The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity, Cell Host Microbe, vol.8, pp.271-283, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00530282
Cross-reacting antibodies enhance dengue virus infection in humans, Science, vol.328, pp.745-748, 2010. ,
Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection, J. Virol, vol.86, pp.2665-2675, 2012. ,
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus, Nat. Immunol, vol.17, pp.1102-1108, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02003950
B cell responses during secondary dengue virus infection are dominated by highly cross-reactive, memory-derived plasmablasts, J. Virol, vol.90, pp.5574-5585, 2016. ,
Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico, vol.169, pp.597-609, 2017. ,
Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection, Emerg. Infect. Dis, vol.23, pp.773-781, 2017. ,
Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans ,
Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort, J. Infect. Dis, vol.211, pp.590-599, 2015. ,
Dengue virus (DENV) neutralizing antibody kinetics in children after symptomatic primary and postprimary DENV infection, J. Infect. Dis, vol.213, pp.1428-1435, 2016. ,
Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort, Proc. Natl. Acad. Sci, vol.113, pp.728-733, 2016. ,
Antibody-dependent enhancement of severe dengue disease in humans, vol.358, pp.929-932, 2017. ,
Research on dengue during World War II, Am. J. Trop. Med. Hyg, vol.1, pp.30-50, 1952. ,
Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections, Am. J. Trop. Med. Hyg, vol.22, pp.365-374, 1973. ,
Incomplete protection against dengue virus type 2 re-infection in Peru, PLoS Neglect. Trop. Dis, vol.10, 2016. ,
Homotypic dengue virus reinfections in Nicaraguan children, J. Infect. Dis, vol.214, pp.986-993, 2016. ,
The immunopathology of dengue and Zika virus infections, Curr. Opin. Immunol, vol.48, pp.1-6, 2017. ,
T cell immunity to dengue virus and implications for vaccine design, Expert Rev. Vaccines, vol.15, pp.443-453, 2016. ,
Participants in the Summit on Dengue Immune Correlates of P Immune correlates of protection for dengue: State of the art and research agenda, vol.35, pp.4659-4669, 2017. ,
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever, Nat. Med, vol.9, pp.921-927, 2003. ,
Altered peptide ligands induce delayed CD8-T cell receptor interaction-A role for CD8 in distinguishing antigen quality, Immunity, vol.25, pp.203-211, 2006. ,
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF, Proc. Natl. Acad. Sci, vol.107, pp.16922-16927, 2010. ,
Dengue virus-reactive CD8 + T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes, J. Immunol, vol.176, pp.2817-2824, 2006. ,
Altered cytokine responses of dengue-specific CD4 + T cells to heterologous serotypes, J. Immunol, vol.175, pp.2676-2683, 2005. ,
T cell responses in dengue hemorrhagic fever: Are cross-reactive T cells suboptimal?, J. Immunol, vol.176, pp.3821-3829, 2006. ,
Partial agonist effect influences the CTL response to a heterologous dengue virus serotype, J. Immunol, vol.163, pp.2754-2760, 1999. ,
The human CD8 + T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes, J. Virol, vol.89, pp.120-128, 2015. ,
Human CD8 + T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets, J. Infect. Dis, vol.212, pp.1743-1751, 2015. ,
Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection, J. Infect. Dis, vol.203, pp.1282-1291, 2011. ,
HLA class I-restricted T cell responses in dengue hemorrhagic fever: A double-edged sword?, J. Infect. Dis, vol.184, pp.1369-1373, 2001. ,
HLA-A and-B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais, Tissue Antigens, vol.60, pp.309-318, 2002. ,
and-DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: Advantages of the Cuban population for HLA studies of dengue virus infection, Hum. Immunol, vol.68, pp.531-540, 2007. ,
Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome ,
Human genetic determinants of dengue virus susceptibility, vol.11, pp.143-156, 2009. ,
HLA class I and class II associations in dengue viral infections in a Sri Lankan population, PLoS ONE, vol.6, 2011. ,
A protective role for dengue virus-specific CD8 + T cells, J. Immunol, vol.182, pp.4865-4873, 2009. ,
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cells, Proc. Natl. Acad. Sci, vol.110, 2013. ,
Increased adaptive immune responses and proper feedback regulation protect against clinical dengue, Sci. Transl. Med, vol.9, 2017. ,
Dengue virus-specific, HLA-B35-restricted, human CD8 + cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities, J. Immunol, vol.154, pp.1287-1295, 1995. ,
Definition of an epitope on NS3 recognized by human CD4 + cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4, Virology, vol.240, pp.169-174, 1998. ,
Differential targeting of viral components by CD4 + versus CD8 + T lymphocytes in dengue virus infection, J. Virol, vol.87, pp.2693-2706, 2013. ,
Defining CD8 + T cell determinants during human viral infection in populations of Asian ethnicity, J. Immunol, vol.191, pp.4010-4019, 2013. ,
Dengue virus infection elicits highly polarized CX3CR1 + cytotoxic CD4 + T cells associated with protective immunity, Proc. Natl. Acad. Sci, vol.112, 2015. ,
Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4 + T-cell clones, J. Virol, vol.70, pp.3108-3117, 1996. ,
Definition of the region on NS3 which contains multiple epitopes recognized by dengue virus serotype-cross-reactive and flavivirus-cross-reactive, HLA-DPw2-restricted CD4 + T cell clones, J. Gen. Virol, vol.79, pp.697-704, 1998. ,
Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections, J. Virol, vol.79, pp.5665-5675, 2005. ,
Identification of conserved and HLA promiscuous DENV3 T-cell epitopes ,
From ZikV genome to vaccine: In silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein, Immunology, vol.149, pp.386-399, 2016. ,
Prediction of promiscuous T-cell epitopes in the Zika virus polyprotein: An in silico approach. Asian Pac, J. Trop. Med, vol.9, pp.844-850, 2016. ,
Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins, Sci. Rep, vol.6, 2016. ,
CD4 + and CD8 + T-cell immunity to Dengue-Lessons for the study of Zika virus, Immunology, vol.150, pp.146-154, 2016. ,
Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8 + T cells, Nat. Microbiol, 2017. ,
T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses ,
Type I Interferon signals in macrophages and dendritic cells control dengue virus infection: Implications for a new mouse model to test dengue vaccines, J. Virol, vol.88, pp.7276-7285, 2014. ,
Mapping and role of the CD8 + T cell response during primary Zika virus infection in mice, Cell Host Microbe, vol.21, pp.35-46, 2017. ,
Dengue virus-reactive CD8 + T cells mediate cross-protection against subsequent Zika virus challenge, Nat. Commun, vol.8, 1459. ,
Vaccine protection against Zika virus from Brazil, Nature, vol.536, pp.474-478, 2016. ,
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys, Science, vol.353, pp.1129-1132, 2016. ,
Cell immunity and Zika virus vaccine development, Trends Immunol, vol.38, pp.594-605, 2017. ,
CD8 + T cell immune response in immunocompetent mice during Zika virus infection, J. Virol, p.91, 2017. ,
Analysis of the T cell response to Zika virus and identification of a novel CD8 + T cell epitope in immunocompetent mice, PLoS Pathog, vol.13, 2017. ,
Adaptive immune responses to Zika virus are important for controlling virus infection and preventing infection in brain and testes, J. Immunol, vol.198, pp.3526-3535, 2017. ,
,
Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans, J. Virol, vol.91, 2017. ,
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner, C.S.H. Perspect. Biol, 2017. ,
CD8 + T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice, J. Immunol, vol.193, pp.4117-4124, 2014. ,
CD8 + T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice, J. Virol, vol.89, pp.6494-6505, 2015. ,